IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#1251
Positioning
Market Dominance
Wholesale Trade
Wholesale
$603M
Ryan S. Napierski
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, nutritional supplements, weight management and body shaping systems, and other products. Nu Skin sells its products under the Nu Skin, Pharmanex, and ageLOC brands.
Headcount
13.4K
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Dates updated upon official exchange announcement.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = NUS ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$ITRN Ituran Location & Control Ltd. | 74 | 95 | 97 | 62 | - | - | 30.4% | 17.5% | 47.8% | 21.2% | 16.8% | 5.1% | 5.1% | 0.0x | $612M | VS | |
$COR Cencora, Inc. | 70 | 84 | 77 | 70 | 21.1x | 11.8x | 123.8% | 2.2% | 3.6% | 0.8% | 0.5% | 9.3% | 0.7% | 508.0x | $60.5B | VS | |
$CENT CENTRAL GARDEN & PET CO | 70 | 84 | 95 | 48 | 5.9x | 3.5x | 10.4% | 4.6% | 31.9% | 8.0% | 5.2% | -2.2% | 0.0% | 75.0x | $2.1B | VS | |
$SNX TD SYNNEX CORP | 67 | 80 | 93 | 57 | 13.5x | 6.2x | 10.0% | 2.6% | 7.0% | 2.3% | 1.3% | 6.9% | 1.2% | 55.0x | $12.4B | VS | |
$HLF HERBALIFE LTD. | 65 | 60 | 75 | 96 | 5.0x | 1.4x | -32.4% | 6.3% | 77.7% | 9.9% | 3.4% | 2.7% | 0.0% | - | $870M | VS | |
$GIC GLOBAL INDUSTRIAL Co | 65 | 82 | 60 | 62 | 18.7x | 12.5x | 24.0% | 12.5% | 35.6% | 7.4% | 5.3% | 3.3% | 2.8% | 0.0x | $1.4B | VS | |
$JXG JX Luxventure Group Inc. | 63 | 84 | 75 | 88 | - | - | 20.4% | 11.9% | 16.8% | 7.8% | 6.2% | 56.5% | 0.0% | 22.0x | $6M | VS | |
$FERG Ferguson Enterprises Inc. /DE/ | 63 | 74 | 48 | 67 | 21.4x | 14.3x | 39.4% | 12.6% | 30.7% | 9.4% | 7.0% | 5.1% | 1.3% | 68.0x | $48.9B | VS | |
$SYY SYSCO CORP | 60 | 68 | 49 | 65 | 22.7x | 9.2x | 89.9% | 5.9% | 18.3% | 3.3% | 1.9% | 3.0% | 2.9% | 595.0x | $35.3B | VS | |
$DXPE DXP ENTERPRISES INC | 60 | 58 | 55 | 79 | 21.6x | 8.5x | 25.1% | 6.2% | 31.4% | 8.5% | 4.2% | 8.6% | 0.0% | 128.0x | $1.9B | VS | |
$NUS NU SKIN ENTERPRISES, INC. | 55 | 61 | 88 | 51 | 2.7x | 6.9x | 19.1% | 11.0% | 69.3% | 3.9% | 10.4% | -17.1% | 2.0% | 75.0x | $603M | ||
| SECTOR BENCH | - | - | - | - | - | 19.1x | 8.2x | 8.6% | 2.7% | 22.5% | 3.3% | 1.4% | 3.3% | 0.3% | 0.5x | - | REF |
NU SKIN ENTERPRISES, INC. (NUS) receives a "Hold" rating with a composite score of 55.2/100. It ranks #1251 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Ryan S. Napierski
Chief Executive Officer
Labor Force
13,400
61
34
36
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for NUS
HQ Base
Wilmington, Utah
In-line with peers — no strong momentum signal
Trading at a discount to fundamentals — favorable entry valuation
High profitability & efficiency — strong quality floor supports entry
Average volatility — neutral timing signal
Aggressive spending — empire-building risk, dilutive growth
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Wholesale Trade sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for NUS.
View All RatingsEarnings well-supported by fundamental cash flows
Material decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 61 | 69 | -8DRAG |
| MOMENTUM | 51 | 48 | +3NEUTRAL |
| VALUATION | 88 | 97 | -9DRAG |
| INVESTMENT | 34 | 52 | -18DRAG |
| STABILITY | 36 | 30 | +6ALPHA |
| SHORT INT | 70 | 86 | -16DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy 19.1% (sector 8.6%)
GM 69% vs sector 22%, OM 4% vs sector 3%
Capital turnover N/A, R&D intensity 0.7%
Rev growth -17%, 10yr history
Interest coverage 15.9x, Net debt/EBITDA -0.3x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns NU SKIN ENTERPRISES, INC. a Hold rating, with a composite score of 55.2/100 and 3 out of 5 stars. Ranked #1251 of 7,333 stocks, NUS presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
With a quality score of 61/100, NUS shows adequate but unremarkable business quality. The company reports a return on equity of 19.1% (sector avg: 8.6%), gross margins of 69.3% (sector avg: 22.5%), net margins of 10.4% (sector avg: 1.4%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
NUS carries a solid value score of 88/100, pointing to an attractively priced stock relative to peers. Key valuation metrics include a P/E ratio of 2.72x, an EV/EBITDA of 6.90x, a P/B ratio of 0.52x. This score suggests reasonable compensation for the risks involved, with potential upside if the market recognizes the stock's underlying worth.
NU SKIN ENTERPRISES, INC.'s investment score of 34/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -17.1% vs. a sector average of 3.3% and a return on assets of 11.0% (sector: 2.7%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
NUS demonstrates moderate momentum with a score of 51/100, suggesting a neutral price trend without strong directional conviction. Revenue growth stands at -17.1% year-over-year, while a beta of 0.94 reflects its sensitivity to broader market moves. Moderate momentum may indicate the stock is consolidating or transitioning between trends, warranting close monitoring of upcoming catalysts.
NUS's stability score of 36/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of 0.94 and a debt-to-equity ratio of 75.00x (sector avg: 0.5x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
NUS carries a short interest score of 70/100, indicating moderate short selling activity. This is a neutral reading — not enough to signal systemic bearishness, but worth monitoring. Specific risk factors include elevated leverage (D/E: 75.00x), small-cap liquidity risk. At $603M market cap (small-cap), NU SKIN ENTERPRISES, INC. offers reasonable institutional liquidity.
NUS offers a modest dividend yield of 2.0%. This compares to a sector average dividend yield of 0.3%. While the income contribution is relatively small, even a small dividend signals management's commitment to shareholder returns and can serve as a signal of financial discipline.
NU SKIN ENTERPRISES, INC. is a small-cap company in the Wholesale Trade sector, ranked #25 of 50 in its sector (50th percentile) and #1251 of 7,333 overall (83rd percentile). Key comparisons include ROE of 19.1% exceeding the 8.6% sector median and operating margins of 3.9% above the 3.3% sector average. This above-median position indicates NUS is outperforming a majority of its Wholesale Trade peers, though there is room to close the gap with sector leaders.
While NUS currently exhibits a HOLD profile, superior opportunities exist within the WHOLESALE TRADE sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Wholesale Trade Alpha →Quant Factor Profile
Key factor gap
Value (88) vs Investment (34) — closing this gap could shift the rating.
RANK #25 OF 50 IN CONSUMER STAPLES
EV/EBITDA 16% BELOW SECTOR MEDIAN (FAVORABLE)
ROE 123% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 208% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate NU SKIN ENTERPRISES, INC. (NUS) as a Hold with a composite score of 55.2/100 at a current price of $8.48. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in value (88th percentile) and quality (61th percentile), which together account for the majority of the composite score. Offsetting weakness in investment (34th percentile) and stability (36th percentile) tempers our overall conviction. We assign a Narrow Moat rating (52/100), Medium uncertainty, and Standard capital allocation.
Key items to watch: quarterly earnings execution and sector-level competitive dynamics. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
NU SKIN ENTERPRISES, INC. holds an above-average position (#25 of 50) within the Wholesale Trade sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 55.2/100 places it at rank #1251 in our full 7,333-stock universe. At $603M in market capitalization, NU SKIN ENTERPRISES, INC. is a small-cap player in the Wholesale Trade space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue contraction of -17% combined with momentum at the 51th percentile paints a cautious picture of the near-term business outlook. The market appears to be pricing in continued challenges, and a catalyst for reversal is not clearly visible from current data.
The margin cascade tells an important story: gross margins of 69% (+46.8pp vs sector) narrow to operating margins of 4% (+0.6pp vs sector) and net margins of 10.4%, yielding a gross-to-net conversion rate of 15%. This conversion rate is typical for the sector, suggesting a standard cost structure without notable efficiency advantages or disadvantages.
At a current price of $8.48, NU SKIN ENTERPRISES, INC. appears undervalued relative to its fundamentals. Our value factor score of 88/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The stock screens as attractively priced on a majority of these measures, suggesting the market may be underappreciating the underlying fundamentals.
The stock currently trades at a P/E of 2.7x (a 86% discount to the sector median of 19.1x), EV/EBITDA of 6.9x (near the sector median), P/B of 0.5x, P/S of 0.3x. The below-sector P/E suggests possible undervaluation or the market pricing in near-term headwinds.
Gross margins of 69% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Returns on equity of 19.1% exceed the cost of equity for most companies, indicating genuine shareholder value creation and a reinvestment engine that compounds wealth over time.
A value factor score of 88/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
Return on assets of 11.0% indicates efficient deployment of the full asset base, not just equity capital.
Revenue decline of -17% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
We assign a Medium uncertainty rating to NU SKIN ENTERPRISES, INC.. The stock presents a balanced risk profile: below-average price stability (36th percentile). While not risk-free, the core business fundamentals are adequate to withstand moderate economic stress, and the range of potential outcomes around our fair value estimate is manageable.
Specific risk factors that inform our assessment include: below-average price stability (36th percentile). Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 36th percentile and quality factor at the 61th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 69% provide a buffer against cost pressures. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate NU SKIN ENTERPRISES, INC.'s capital allocation as Standard. Management has shown adequate — though not exceptional — stewardship of shareholder capital. Returns on equity stand at 19.1%, and the balance sheet is managed within acceptable parameters (D/E: 75%). Exemplary allocators typically sustain ROE above 20% and D/E below 50%; NU SKIN ENTERPRISES, INC. falls short on at least one dimension.
There is room for improvement in optimizing the capital structure or enhancing shareholder returns. The 1.97% dividend yield provides some income return, but the overall capital allocation framework would benefit from either higher reinvestment returns, improved balance sheet efficiency, or increased shareholder distributions. We will monitor for signs of strategic improvement that could warrant an upgrade.
In summary, NU SKIN ENTERPRISES, INC. receives a Hold rating with a composite score of 55.2/100 (rank #1251 of 7,333). Our quantitative framework assigns a Narrow Moat (52/100, trend: stable), Medium uncertainty, and Standard capital allocation. The average factor score across quality, value, momentum, stability, and investment is 54/100.
Our analysis supports a neutral stance on NU SKIN ENTERPRISES, INC.. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We assign NU SKIN ENTERPRISES, INC. a Narrow Moat rating with a composite moat score of 52/100. The company possesses identifiable competitive advantages, though they are less entrenched than those of wide-moat peers. Our analysis indicates that NU SKIN ENTERPRISES, INC. can sustain above-average returns on invested capital for at least 10 years, with the strongest contributor being financial resilience at 19.2/20.
The strongest moat sources are financial resilience (19.2/20) and margin superiority (16.5/20). Interest coverage 15.9x, Net debt/EBITDA -0.3x. GM 69% vs sector 22%, OM 4% vs sector 3%. These pillars form the core of NU SKIN ENTERPRISES, INC.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (0.3/20) and growth durability (2.8/20). Capital turnover N/A, R&D intensity 0.7%. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect NU SKIN ENTERPRISES, INC.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 69% providing a solid profitability foundation, declining revenues (-17%) that pressure the earnings outlook, returns on equity of 19.1% driving shareholder value creation. The margin cascade from 69% gross to 4% operating to 10.4% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that the profit engine is high-quality and likely sustainable, with the quality factor at the 61th percentile.
The margin profile shows gross margins of 69%, operating margins of 4%, net margins of 10.4%. Return metrics include ROE of 19.1% and ROA of 11.0%. Relative to the Wholesale Trade sector, gross margins are 46.8 percentage points above the sector median of 22%, and ROE of 19.1% compares to a sector median of 8.6%.
The balance sheet reflects moderate leverage with D/E of 75%, a dividend yield of 1.97%, revenue growth of -17%. The sector median D/E is 1%, putting NU SKIN ENTERPRISES, INC. at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
Elevated short interest (70th percentile) indicates that sophisticated market participants are betting against the stock.
Nu Skin's (NUS) first-quarter 2024 results reflect challenges related to volatile currency movements, while cost-management efforts work well.
Above 50MA
37.18%
Net New Highs
+51081